Literature DB >> 20427990

Acute kidney injury: classification and staging.

Dinna N Cruz, Sean M Bagshaw, Claudio Ronco, Zaccaria Ricci.   

Abstract

It was not until recently that consensus definitions for acute kidney injury (AKI) were proposed and published. The RIFLE (Risk-Injury-Failure-Loss-End-stage renal disease) and AKIN (Acute Kidney Injury Network) classifications were designed in order to be easily understood and applied in a variety of clinical and research settings. Their creation was intended to uniformly establish the presence or absence of the AKI and to give a quantitative idea of the severity of the disease unifying the commonly used parameters of serum creatinine and urine output. Subsequent validation showed that both the presence and severity of AKI, defined using RIFLE/AKIN, correlate well with patient outcome. This review will briefly describe the RIFLE/AKIN consensus definitions, its subsequent revisions and its successful validation and application to clinical research. The potential of extending the use of RIFLE/AKIN to the clinical setting of cardiorenal syndromes is also discussed. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20427990     DOI: 10.1159/000313717

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  23 in total

1.  Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.

Authors:  Wen-Ling Ye; Nan Tang; Yu-Bing Wen; Hang Li; Min-Xi Li; Bin Du; Xue-Mei Li
Journal:  Int Urol Nephrol       Date:  2016-06-28       Impact factor: 2.370

2.  Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.

Authors:  Abolfazl Zarjou; Junghyun Kim; Amie M Traylor; Paul W Sanders; József Balla; Anupam Agarwal; Lisa M Curtis
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

3.  [Clinical features and prognosis of infective endocarditis patients with acute kidney injury].

Authors:  S Y Zhang; X H Li; F Xiao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

4.  Estimating baseline kidney function in hospitalized patients with impaired kidney function.

Authors:  Edward D Siew; T Alp Ikizler; Michael E Matheny; Yaping Shi; Jonathan S Schildcrout; Ioana Danciu; Jamie P Dwyer; Manakan Srichai; Adriana M Hung; James P Smith; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-15       Impact factor: 8.237

5.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.

Authors:  Francesca Menni; Sara Testa; Sophie Guez; Gabriella Chiarelli; Luisella Alberti; Susanna Esposito
Journal:  Pediatr Nephrol       Date:  2012-03-25       Impact factor: 3.714

Review 6.  Recent advances in acute kidney injury epidemiology.

Authors:  Edward D Siew; Serpil M Deger
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

7.  Determinants and consequences of positive valve culture when cardiac surgery is performed during the acute phase of infective endocarditis.

Authors:  P Fillâtre; A Gacouin; M Revest; A Maamar; S Patrat-Delon; E Flécher; O Fouquet; N Lerolle; J-P Verhoye; Y Le Tulzo; Pierre Tattevin; J-M Tadié
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-26       Impact factor: 3.267

Review 8.  The implications and management of septic acute kidney injury.

Authors:  Zaccaria Ricci; Andrea Polito; Angelo Polito; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

Review 9.  Pathophysiology of ischemic acute kidney injury.

Authors:  Asif A Sharfuddin; Bruce A Molitoris
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

10.  Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research.

Authors:  Edward D Siew; Josh F Peterson; Svetlana K Eden; Karel G Moons; T Alp Ikizler; Michael E Matheny
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.